GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (BSP:MRCK34) » Definitions » E10

Merck (BSP:MRCK34) E10 : R$2.75 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Merck E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Dec. 2024 was R$1.129. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$2.75 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Merck's average E10 Growth Rate was 6.50% per year. During the past 3 years, the average E10 Growth Rate was 6.90% per year. During the past 5 years, the average E10 Growth Rate was 10.50% per year. During the past 10 years, the average E10 Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Merck was 15.90% per year. The lowest was -6.40% per year. And the median was 3.85% per year.

As of today (2025-03-28), Merck's current stock price is R$62.75. Merck's E10 for the quarter that ended in Dec. 2024 was R$2.75. Merck's Shiller PE Ratio of today is 22.82.

During the past 13 years, the highest Shiller PE Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.09.


Merck E10 Historical Data

The historical data trend for Merck's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck E10 Chart

Merck Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.68 2.06 2.24 2.03 2.75

Merck Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.03 2.22 2.62 2.58 2.75

Competitive Comparison of Merck's E10

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.


;
;

Merck E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=1.129/133.1571*133.1571
=1.129

Current CPI (Dec. 2024) = 133.1571.

Merck Quarterly Data

per share eps CPI Adj_EPS
201503 0.130 99.621 0.174
201506 0.093 100.684 0.123
201509 0.312 100.392 0.414
201512 0.170 99.792 0.227
201603 0.185 100.470 0.245
201606 0.184 101.688 0.241
201609 0.317 101.861 0.414
201612 0.176 101.863 0.230
201703 0.219 102.862 0.283
201706 0.292 103.349 0.376
201709 -0.008 104.136 -0.010
201712 -0.133 104.011 -0.170
201803 0.111 105.290 0.140
201806 0.297 106.317 0.372
201809 0.375 106.507 0.469
201812 0.335 105.998 0.421
201903 0.538 107.251 0.668
201906 0.496 108.070 0.611
201909 0.381 108.329 0.468
201912 0.472 108.420 0.580
202003 0.770 108.902 0.942
202006 0.765 108.767 0.937
202009 0.783 109.815 0.949
202012 -0.534 109.897 -0.647
202103 0.880 111.754 1.049
202106 0.383 114.631 0.445
202109 1.188 115.734 1.367
202112 1.046 117.630 1.184
202203 1.057 121.301 1.160
202206 0.978 125.017 1.042
202209 0.839 125.227 0.892
202212 0.774 125.222 0.823
202303 0.723 127.348 0.756
202306 -1.426 128.729 -1.475
202309 1.148 129.860 1.177
202312 -0.294 129.419 -0.302
202403 1.164 131.776 1.176
202406 1.441 132.554 1.448
202409 0.858 133.029 0.859
202412 1.129 133.157 1.129

Add all the adjusted EPS together and divide 10 will get our e10.


Merck  (BSP:MRCK34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=62.75/2.75
=22.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Merck was 39.37. The lowest was 19.66. And the median was 28.09.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Merck E10 Related Terms

Thank you for viewing the detailed overview of Merck's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck Headlines

No Headlines